Literature DB >> 25302656

We need better classification and terminology for "people at high risk of or in the process of developing lupus".

Karen H Costenbader1, Peter H Schur.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25302656      PMCID： PMC4391980          DOI： 10.1002/acr.22484

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN： 2151-464X            Impact factor:   4.794


× No keyword cloud information.
  25 in total

1.  Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).

Authors:  E Bodolay; Z Csiki; Z Szekanecz; T Ben; E Kiss; M Zeher; G Szücs; K Dankó; G Szegedi
Journal:  Clin Exp Rheumatol       Date:  2003 May-Jun       Impact factor: 4.473

2.  Incomplete lupus erythematosus.

Authors:  J M Greer; R S Panush
Journal:  Arch Intern Med       Date:  1989-11

3.  Development of SLE among "potential SLE" patients seen in consultation: long-term follow-up.

Authors:  M Al Daabil; E M Massarotti; A Fine; H Tsao; P Ho; P H Schur; B L Bermas; K H Costenbader
Journal:  Int J Clin Pract       Date:  2014-05-23       Impact factor: 2.503

4.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

5.  Cytokines in relation to autoantibodies before onset of symptoms for systemic lupus erythematosus.

Authors:  C Eriksson; S Rantapää-Dahlqvist
Journal:  Lupus       Date:  2014-02-14       Impact factor: 2.911

6.  Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus.

Authors:  L M Vilá; A M Mayor; A H Valentín; M García-Soberal; S Vilá
Journal:  Lupus       Date:  2000       Impact factor: 2.911

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Systemic lupus erythematosus: predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: multivariate analyses and identification of risk factors.

Authors:  J Calvo-Alen; G S Alarcon; S L Burgard; N Burst; A A Bartolucci; H J Williams
Journal:  J Rheumatol       Date:  1996-03       Impact factor: 4.666

Review 9.  What is lupus? What is not lupus?

Authors:  R S Panush; J M Greer; K K Morshedian
Journal:  Rheum Dis Clin North Am       Date:  1993-02       Impact factor: 2.670

10.  Autoantibody profiling to follow evolution of lupus syndromes.

Authors:  Nancy J Olsen; Quan-Zhen Li; Jiexia Quan; Ling Wang; Azza Mutwally; David R Karp
Journal:  Arthritis Res Ther       Date:  2012-07-27       Impact factor: 5.156
View more
  12 in total

Review 1.  The Clinical Relevance of Anti-DFS70 Autoantibodies.

Authors:  Karsten Conrad; Nadja Röber; Luis E C Andrade; Michael Mahler
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

Review 2.  Preclinical lupus.

Authors:  Rebecka Bourn; Judith A James
Journal:  Curr Opin Rheumatol       Date:  2015-09       Impact factor: 5.006

3.  Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features.

Authors:  Melissa E Munroe; Kendra A Young; Diane L Kamen; Joel M Guthridge; Timothy B Niewold; Karen H Costenbader; Michael H Weisman; Mariko L Ishimori; Daniel J Wallace; Gary S Gilkeson; David R Karp; John B Harley; Jill M Norris; Judith A James
Journal:  Arthritis Rheumatol       Date:  2017-03       Impact factor: 10.995

Review 4.  The use and abuse of diagnostic/classification criteria.

Authors:  Rayford R June; Rohit Aggarwal
Journal:  Best Pract Res Clin Rheumatol       Date:  2015-05-23       Impact factor: 4.098

5.  Clinical and Serologic Features in Patients With Incomplete Lupus Classification Versus Systemic Lupus Erythematosus Patients and Controls.

Authors:  Teresa Aberle; Rebecka L Bourn; Melissa E Munroe; Hua Chen; Virginia C Roberts; Joel M Guthridge; Krista Bean; Julie M Robertson; Kathy L Sivils; Astrid Rasmussen; Meghan Liles; Joan T Merrill; John B Harley; Nancy J Olsen; David R Karp; Judith A James
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-11-14       Impact factor: 4.794

Review 6.  Understanding the Concept of Pre-Clinical Autoimmunity: Prediction and Prevention of Systemic Lupus Erythematosus: Identifying Risk Factors and Developing Strategies Against Disease Development.

Authors:  May Y Choi; Karen H Costenbader
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

7.  Clinical and Immunologic Profiles in Incomplete Lupus Erythematosus and Improvement with Hydroxychloroquine Treatment.

Authors:  Nancy J Olsen; Carl McAloose; Jamie Carter; Bobby Kwanghoon Han; Indu Raman; Quan-Zhen Li; Duanping Liao
Journal:  Autoimmune Dis       Date:  2016-12-28

8.  Presence of an interferon signature in individuals who are anti-nuclear antibody positive lacking a systemic autoimmune rheumatic disease diagnosis.

Authors:  Joan Wither; Sindhu R Johnson; Tony Liu; Babak Noamani; Dennisse Bonilla; Larissa Lisnevskaia; Earl Silverman; Arthur Bookman; Carolina Landolt-Marticorena
Journal:  Arthritis Res Ther       Date:  2017-02-28       Impact factor: 5.156

9.  SLE: reconciling heterogeneity.

Authors:  Michael D Lockshin; Medha Barbhaiya; Peter Izmirly; Jill P Buyon; Mary K Crow
Journal:  Lupus Sci Med       Date:  2019-02-04

10.  2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.

Authors:  Martin Aringer; Karen Costenbader; David Daikh; Ralph Brinks; Marta Mosca; Rosalind Ramsey-Goldman; Josef S Smolen; David Wofsy; Dimitrios T Boumpas; Diane L Kamen; David Jayne; Ricard Cervera; Nathalie Costedoat-Chalumeau; Betty Diamond; Dafna D Gladman; Bevra Hahn; Falk Hiepe; Søren Jacobsen; Dinesh Khanna; Kirsten Lerstrøm; Elena Massarotti; Joseph McCune; Guillermo Ruiz-Irastorza; Jorge Sanchez-Guerrero; Matthias Schneider; Murray Urowitz; George Bertsias; Bimba F Hoyer; Nicolai Leuchten; Chiara Tani; Sara K Tedeschi; Zahi Touma; Gabriela Schmajuk; Branimir Anic; Florence Assan; Tak Mao Chan; Ann Elaine Clarke; Mary K Crow; László Czirják; Andrea Doria; Winfried Graninger; Bernadett Halda-Kiss; Sarfaraz Hasni; Peter M Izmirly; Michelle Jung; Gábor Kumánovics; Xavier Mariette; Ivan Padjen; José M Pego-Reigosa; Juanita Romero-Diaz; Íñigo Rúa-Figueroa Fernández; Raphaèle Seror; Georg H Stummvoll; Yoshiya Tanaka; Maria G Tektonidou; Carlos Vasconcelos; Edward M Vital; Daniel J Wallace; Sule Yavuz; Pier Luigi Meroni; Marvin J Fritzler; Ray Naden; Thomas Dörner; Sindhu R Johnson
Journal:  Arthritis Rheumatol       Date:  2019-08-06       Impact factor: 15.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.